Aashka Hospitals

Which are the latest news on Aashka Hospitals?

Why is Aashka Hospitals Ltd falling/rising?

As of 05-Sep, Aashka Hospitals Ltd's stock price is at 84.85, showing no change and indicating a potential shift in momentum after a trend reversal. The stock has seen declining investor participation and erratic trading, suggesting it is under pressure despite outperforming the Sensex in recent periods.

As of 05-Sep, Aashka Hospitals Ltd's stock price is currently at 84.85, showing no change from the previous trading session. The stock has experienced a trend reversal, having fallen after three consecutive days of gains. This suggests a potential shift in momentum. Additionally, the stock's trading activity has been erratic, as it did not trade on two out of the last twenty days, indicating a lack of consistent investor interest.<BR><BR>Moreover, there has been a notable decline in investor participation, with the delivery volume on September 2 dropping by 68.75% compared to the five-day average. This decrease in trading volume can often signal waning interest from investors, which may contribute to the stock's stagnation in price. <BR><BR>Despite these factors, Aashka Hospitals Ltd has performed well compared to the benchmark Sensex over various periods, including a 13.89% increase over the past week and a 16.71% increase over the past month. However, the stock is currently trading below its 200-day moving average, which may indicate a longer-term bearish trend. Overall, the combination of a recent trend reversal, declining investor participation, and erratic trading patterns suggests that the stock's price is currently under pressure.

Who are in the management team of Aashka Hospitals?

The management team of Aashka Hospitals includes Bipinchandra Shah (Chairman & Managing Director), Dr. Parag Thaker and Shreyarthi Shah (Directors), Hiteshkumar Shah (Independent Director), Umang Shah (Additional Director), and Mayank Agarwal (Company Secretary & Compliance Officer).

The management team of Aashka Hospitals includes the following individuals:<BR><BR>- Bipinchandra Shah serves as the Chairman & Managing Director.<BR>- Dr. Parag Thaker is a Director.<BR>- Shreyarthi Shah also holds the position of Director.<BR>- Hiteshkumar Shah is an Independent Director.<BR>- Umang Shah is an Additional Director.<BR>- Mayank Agarwal acts as the Company Secretary & Compliance Officer.<BR><BR>If you have any more questions about Aashka Hospitals or its operations, feel free to ask!

What does Aashka Hospitals do?

Aashka Hospitals Ltd is a micro-cap company in the hospital industry, incorporated in 2012. It currently has no available revenue or profit data, with a market cap of INR 176 Cr and a P/E ratio of 62.00.

Overview:<BR>Aashka Hospitals Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Aashka Hospitals Limited was originally incorporated as a Private Limited Company under the name "Aashka Hospitals Private Limited" on November 09, 2012. There are no reported status changes, and revenue and profit data are not available for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 176 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 62.00<BR>Industry P/E: N/A<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.04<BR>Return on Equity: 2.74%<BR>Price-to-Book: 1.70<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the peers of the Aashka Hospitals?

Aashka Hospitals' peers include Asarfi Hospital, Lotus Eye Hospital, Fortis Malar, and Nephro Care, among others. Nephro Care shows excellent management and growth, while Aashka Hospitals has a 1-year return of -6.88%, better than Abate As Indust's -45.64% but lower than Asarfi Hospital's 77.75%.

Peers: The peers of Aashka Hospitals are Asarfi Hospital, Lotus Eye Hospit, Abate As Indust, Fortis Malar, Vaidya Sane, Nephro Care, Aprameya Enginee, KHFM Hospitality, and Maitreya Medica.<BR><BR>Quality Snapshot: Excellent management risk is observed at Nephro Care and Aprameya Enginee, while Average management risk is found at Asarfi Hospital, and the rest have Below Average management risk. Growth is Excellent at Nephro Care, Good at Asarfi Hospital and Vaidya Sane, Average at Vaidya Sane, and the rest have Below Average growth. Capital Structure is Good at Asarfi Hospital, Vaidya Sane, and Aprameya Enginee, Average at Aashka Hospitals and Abate As Indust, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Asarfi Hospital at 77.75%, while the peer with the lowest is Abate As Indust at -45.64%. Aashka Hospitals has a 1-year return of -6.88%, which is higher than Abate As Indust but lower than Asarfi Hospital. Additionally, Fortis Malar, Abate As Indust, and KHFM Hospitality have negative six-month returns.

How big is Aashka Hospitals?

As of 13th August, Aashka Hospitals Ltd has a market capitalization of 167.00 Cr, classifying it as a Micro Cap company, with no valid financial data available for the latest four quarters. The latest annual report shows Shareholder's Funds of 99.54 Cr and Total Assets of 116.05 Cr.

As of 13th August, <BR><BR>Market Cap: Aashka Hospitals Ltd has a market capitalization of 167.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for the latest four quarters, including Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: The latest annual reporting period is March 2025, with Shareholder's Funds amounting to 99.54 Cr and Total Assets valued at 116.05 Cr.

How has been the historical performance of Aashka Hospitals?

Aashka Hospitals has experienced fluctuating financial performance, with net sales declining from INR 39.73 crore in March 2022 to INR 22.65 crore in March 2025, while profitability improved, moving from a loss in March 2023 to profits by March 2025. Despite a decrease in total assets, cash flow from operations significantly improved, reaching INR 9 crore in March 2025.

Answer:<BR>The historical performance of Aashka Hospitals shows fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Aashka Hospitals' net sales have seen a decline from INR 39.73 crore in March 2022 to INR 22.65 crore in March 2025, with a slight decrease from INR 22.87 crore in March 2024. The total operating income followed a similar trend, peaking at INR 39.73 crore in March 2022 and dropping to INR 22.65 crore by March 2025. The total expenditure, excluding depreciation, decreased from INR 31.47 crore in March 2022 to INR 18.37 crore in March 2025. Operating profit (PBDIT) also fluctuated, reaching a high of INR 9.92 crore in March 2021 but falling to INR 4.28 crore in March 2025. Profit before tax improved from a loss of INR 2.57 crore in March 2023 to a profit of INR 3.87 crore in March 2025. Profit after tax followed suit, moving from a loss of INR 2.57 crore in March 2023 to a profit of INR 3.27 crore in March 2025. The company's total assets decreased from INR 129.12 crore in March 2022 to INR 116.05 crore in March 2025, while total liabilities also declined from INR 129.12 crore to INR 116.05 crore during the same period. Cash flow from operating activities improved significantly, reaching INR 9 crore in March 2025, compared to a negative cash flow of INR 62 crore in March 2022. Overall, Aashka Hospitals has shown a recovery in profitability and cash flow in recent years, despite a decline in sales and total assets.

Who are the top shareholders of the Aashka Hospitals?

The top shareholder of Aashka Hospitals is Bipinchandra Dineshbhai Shah, holding 49.63%, with no pledged promoter holdings. The highest public shareholder is Mohit Prakash Jalan at 2.38%, while individual investors own 30.16% of the shares.

The top shareholders of Aashka Hospitals are primarily the promoters, with Bipinchandra Dineshbhai Shah holding the largest share at 49.63%. There are no pledged promoter holdings, and the company does not have any mutual fund or foreign institutional investor (FII) holdings. The highest public shareholder is Mohit Prakash Jalan, who holds 2.38%. Additionally, individual investors collectively hold 30.16% of the company's shares.

Is Aashka Hospitals overvalued or undervalued?

As of May 27, 2025, Aashka Hospitals is considered overvalued with a PE ratio of 91.61 and an EV to EBITDA of 57.47, significantly higher than its peers, despite a low ROE of 2.58% and recent underperformance compared to the market.

As of 27 May 2025, Aashka Hospitals has moved from a grade of "does not qualify" to "very expensive." The company is currently overvalued, with a PE ratio of 91.61, an EV to EBITDA of 57.47, and a ROE of 2.58%. In comparison, peers such as Apollo Hospitals Enterprise Ltd. have a significantly lower PE ratio of 69.03 and an EV to EBITDA of 34.71, while Fortis Healthcare Ltd. stands at a PE of 68.71 and an EV to EBITDA of 37.55, indicating that Aashka is trading at a premium relative to its competitors.<BR><BR>The high valuation metrics suggest that Aashka Hospitals is not justified by its financial performance, especially considering its low ROCE of 1.16%. Additionally, while the stock has shown strong performance over the past year with a return of 21.56% compared to the Sensex's 7.55%, the year-to-date performance of -11.11% against the Sensex's 5.56% indicates a potential correction ahead. Overall, the current valuation does not align with the company's financial fundamentals, reinforcing the conclusion that Aashka Hospitals is overvalued.

What is the technical trend for Aashka Hospitals?

As of April 30, 2025, Aashka Hospitals exhibits a mildly bearish trend, driven by bearish MACD and moving averages, despite some mixed signals from Bollinger Bands and KST.

As of 30 April 2025, the technical trend for Aashka Hospitals has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD is mildly bearish, indicating a negative momentum shift. The daily moving averages also reflect a bearish stance. Although the weekly Bollinger Bands are bearish, the monthly Bollinger Bands show a mildly bullish outlook, suggesting some potential for recovery. The KST indicates a mildly bullish trend on the weekly and bullish on the monthly, which contrasts with the overall bearish sentiment. The Dow Theory shows no trend on the weekly and mildly bearish on the monthly, further supporting the bearish outlook. Overall, the current stance is mildly bearish, driven primarily by the bearish indicators in MACD and moving averages, despite some mixed signals from KST and Bollinger Bands.

When is the next results date for Aashka Hospitals?

No Upcoming Board Meetings

Has Aashka Hospitals declared dividend?

No Dividend History Available